Chien, Chia-Hung
Yang, Wen-Bin
Chuang, Jian-Ying
Lee, Jung-Shun
Liao, Wei-An
Huang, Chih-Yuan
Chen, Pin-Yuan
Wu, An-Chih
Yang, Shun-Tai
Lai, Chien-Cheng
Chi, Pei-I
Chu, Jui-Mei
Cheng, Siao Muk
Liu, Chan-Chuan
Hwang, Daw-Yang
Chen, Shang-Hung
Chang, Kwang-Yu https://orcid.org/0000-0002-5240-2760
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 110-2314-B-400-030)
National Health Research Institutes (CA-110-PP-19)
National Cheng Kung University Hospital (NCKUH-11009024)
Article History
Received: 22 February 2022
Accepted: 2 July 2022
First Online: 13 July 2022
Declarations
:
: The application of clinical tumor samples for IHC staining and scRNA transcriptome was approved by the IRB of National Cheng Kung University Hospital (A-ER-109-039) and National Health Research Institutes (EC1080202). The application of the 14 RNA-seq data were approved by the IRB of Chang Gung Medical Hospital (201800077B0).All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of National Health Research Institutes (NHRI-IACUC-108048-A).
: Not applicable.
: The authors declared no potential competing interests.